Nongestational ovarian choriocarcinoma (NGCO) is a tumor of germ cell origin seldom described in nonhuman species. Few spontaneous cases are reported in macaques and mice, with the B6C3F1 strain overrepresented. This report describes 2 cases of ovarian choriocarcinoma in nulliparous female mice with conditional loss of Trp53 under the Tie2 promoter. The mouse line was maintained on a mixed genetic background including Crl: CD1(ICR) and 129X1/SvJ strains. In both cases, affected ovary was partially replaced by blood-filled lacunae lined by neoplastic trophoblast-like giant cells. Immunohistochemically, neoplastic cells expressed folate-binding protein and prolactin and were invariably negative for p53. To the authors' knowledge, this is the first report characterizing this entity in a genetically engineered mouse (GEM) line. Considering that germ cells (the cell population from which NGCO originates) constitutively express Tie2 receptor, it can be speculated that Tie2-driven deletion of Trp53 may have played a role in the development of these tumors.
Keywords choriocarcinoma, genetically engineered mouse, ovary, Trp53Choriocarcinoma is a rare highly malignant hormonally functional tumor. This entity currently encompasses 3 distinct neoplastic conditions: (1) gestational choriocarcinoma of trophoblastic origin primarily located in the uterus and arising after a gestational event, (2) gonadal or extragonadal (usually midline locations) nongestational choriocarcinoma of germ cell origin, and (3) nongestational choriocarcinoma arising in the context of a poorly differentiated somatic carcinoma. 4 Nongestational choriocarcinoma of the ovary (NGCO) is an extremely rare tumor that accounts for less than 1% of all human ovarian malignancies.4 NGCO most commonly affects children and women younger than 20 years of age.4 NGCO frequently coexists with other neoplasms of germ cell origin such as seminoma, embryonal carcinoma, yolk sac tumor, and teratoma in the same or contralateral ovary, with the pure form being exceedingly rare. 4 As seen also for the other gestational and nongestational variants of choriocarcinoma, the development of NGCO is typically accompanied by high levels of human chorionic gonadotropin (hCG) in serum and urine. The distinction between NGCO and the gestational counterpart is warranted because of the worse prognosis of NGCO, mainly due to its metastatic potential to brain and lungs. 4 Primary ovarian choriocarcinomas are also extremely rare in laboratory animals. Surveys of ovarian tumors in rats have failed to reveal any cases.2 Primary unilateral ovarian choriocarcinomas arising spontaneously have been reported only twice as incidental findings in nonhuman primates.
7Reports of ovarian choriocarcinomas in mice are exceedingly rare, with B6C3F1 strain overrepresented and just 1 study mentioning (but not further characterizing) a single case in genetically engineered mice (GEM) carrying a targeted null mutation of both Hic1 and